Resistance through chromosomal mutation
Target modification: Bacterial GyrAThe bacterial protein GyrA is essential for maintaining DNA structure, and is targeted by fluoroquinolone antibiotics. The antibiotics block the DNA-binding part of GyrA, which can then no longer carry out its function. Bacteria can become resistant to fluoroquinolone antibiotics by acquiring mutations in the gene encoding GyrA that reduce fluoroquinolone binding, but without changing its DNA-binding ability. Bacteria with the mutation can survive and grow in the presence of this class of antibiotic, and will outcompete bacteria without the mutation. This mechanism of resistance is common in the bacterium that causes tuberculosis, so that use of fluoroquinolones alone is no longer recommended.
Increased expression of efflux pumpsWe learned in the previous section that many bacteria use efflux pumps to expel antibiotics. Chromosomal mutations can increase the production of efflux pumps by altering the proteins that regulate their levels. Overproduction of efflux pumps will increase resistance to the class of drug targeted by the pump.
Effect of resistance on bacterial populationsAll antibiotics can be circumvented by evolved chromosomal mutations, though the frequency of mutation varies based on the bacterial species and the antibiotic. The background mutation of a bacterium will produce antibiotic resistant variants by chance even when no antibiotic is present. A typical bacterial population contains billions of cells and these grow quickly, so even though AMR mutations are extremely rare, they still occur on medically-relevant timescales. Variants with these beneficial AMR mutations can dominate a population rapidly if an antibiotic is encountered (Figure 1). Some resistance mutations are also damaging for the bacterium; in these cases, the mutation will not continue to dominate and the population will eventually revert to being antibiotic-sensitive. However, these slight negative effects can often be compensated for by further mutations elsewhere on the chromosome. In addition, some resistance mutations do not have any other costs. In these cases, the population will remain antibiotic-resistant even when grown without the selective pressure of the antibiotic for a long time.Figure 1 (Click image to expand) Schematic of a bacterial population treated by an antibiotic. Resistance mutations are very rare, but mutants will survive and multiply during antibiotic treatment while other cells are killed. When the antibiotic is taken away, the result for the population depends on whether the resistance mutation has any adverse effects for the bacterium. If not, the population can stay resistant for an extended time. © Francesca Short 2017
Bacterial Genomes: Disease Outbreaks and Antimicrobial Resistance
Our purpose is to transform access to education.
We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.
We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.